German Luxury Stock News

AIXTRON (XTRA:AIXA) is back in focus after first quarter results showed sales of €59.38 million and a net loss of €21.94 million, while management highlighted strong optoelectronics orders linked to AI datacenter demand. See our latest analysis for AIXTRON. Despite the weak first quarter, AIXTRON's share price has surged recently, with a 30 day share price return of 41.17% and a 1 year total shareholder return of 267.80%. This suggests momentum has picked up as investors weigh AI linked order...

If you are wondering whether DWS Group GmbH KGaA is fairly priced right now, the key question is whether the current share price lines up with its underlying value. The stock last closed at €59.00, with returns of 3.5% over 7 days, 6.5% over 30 days, 4.6% year to date and 30.3% over 1 year, alongside a very large 3 year return and 135.5% over 5 years. Recent coverage has focused on DWS Group GmbH KGaA as an asset manager, which can affect how investors think about its fee resilience, cost...

Record 2025 results bring GEA Group (XTRA:G1A) into focus GEA Group (XTRA:G1A) is back on many investors’ radars after reporting a record 2025, highlighting 9.1% organic order intake growth, a proposed dividend of €1.30 per share, and detailed guidance for 2026. See our latest analysis for GEA Group. Despite record 2025 results, GEA Group’s share price has eased recently, with a 7 day share price return of 4.27% and a 30 day share price return of 6.11%. However, longer term total shareholder...

If you are wondering whether flatexDEGIRO's share price still offers value at current levels, the key question is how its market price compares with its underlying fundamentals. The stock recently closed at €30.48, with returns of 0.2% over 7 days, 1.4% over 30 days, a 16.0% decline year to date, and 29.2% over the last year. Together, these figures give mixed signals about how the market is pricing its prospects and risks. Recent coverage has focused on flatexDEGIRO's position within online...

Fresenius Medical Care (XTRA:FME) has amended its distribution agreement with Humacyte, Inc. regarding Symvess, an investigational acellular tissue engineered vessel. The revision realigns ex U.S. rights to Symvess and reshapes how the two companies coordinate on access to this advanced vascular product outside the United States. For you as an investor, this move sits at the intersection of medical technology and chronic kidney care, where XTRA:FME is a major global provider. Access to next...

While Clearway Energy, Inc. ( FRA:NY4B ) might not have the largest market cap around , it saw a significant share...

If you are wondering whether Bayerische Motoren Werke is attractively priced right now, the starting point is understanding how the current share price lines up against a grounded estimate of value. The stock closed at €77.92 most recently, with a 1.8% decline over the last 7 days, a 1.7% decline over 30 days, a 19.1% decline year to date, but a 9.9% gain over the past year. These mixed returns give you a picture of a share price that has shifted meaningfully over different time frames,...

Allianz at a Glance: Recent Returns and Business Mix Allianz (XTRA:ALV) has drawn attention after a period where the share price shows a 1 day return of 1.1%, a 7 day return of 0.3%, and around 5.7% over the past month. For context, Allianz reports annual revenue of €113.2b and net income of €10.6b, with annual revenue growth of 9.1% and net income growth of 6%. The group operates across property casualty, life and health insurance, and asset management. See our latest analysis for...

Wacker Chemie (XTRA:WCH) has caught investor attention after reporting Q1 EBITDA of €173 million, a 45% year-over-year increase, supported by its PACE cost program and upgraded full-year 2026 sales expectations. See our latest analysis for Wacker Chemie. Wacker Chemie’s share price has moved to €93.65, with a 30-day share price return of 14.14% and a 90-day return of 35.53%. The 1-year total shareholder return of 44.43% contrasts with weaker 3 and 5-year total returns, suggesting momentum has...

adidas AG ( ETR:ADS ) is about to trade ex-dividend in the next four days. The ex-dividend date is commonly two...

Porsche has unveiled the all electric Cayenne Coupé at a world premiere event in Beijing. The launch extends electrification to one of Porsche's core SUV nameplates within the Cayenne range. The new model introduces updated design elements and e performance options in the premium SUV segment. For investors watching Dr. Ing. h.c. F. Porsche (XTRA:P911), the Cayenne Coupé Electric adds a fresh catalyst to a share price that last closed at €41.25. Over the past month the stock has returned...

Wondering if Rheinmetall at €1,355.80 is pricing in too much optimism or leaving room on the table for value focused investors like you? The stock is up 2.8% over the last week, but shows a 13.7% decline over 30 days, a 15.4% decline year to date, and a 13.5% decline over the past year, all following a very large 3 year gain and an even larger 5 year gain. Recent coverage has focused on Rheinmetall's position in defense and capital goods, which often draws attention whenever sector sentiment...

BASF (XTRA:BAS) has just opened 2026 with Q1 numbers that cap a year where trailing twelve month revenue sat at about €59.7b and basic EPS came in at €1.61. Over recent quarters, the company has seen revenue move from €17.6b and EPS of €1.53 in Q1 2024 to €14.0b and EPS of €0.57 in Q4 2025, with trailing net income from continuing operations at €1.43b across the last reported twelve months. With net profit margins over the past year at 2.4% and earnings growth of 26.6% supported by forecasts...

If you are wondering whether Mercedes-Benz Group shares are offering good value right now, the key is to separate price moves from what the underlying business may be worth. The stock last closed at €49.59, with returns of 8.2% over 1 year, 18.0% over 5 years, and shorter term moves of a 0.4% decline over 7 days, a 5.9% decline over 30 days, and a 19.9% decline year to date. Recent coverage has focused on Mercedes-Benz Group as a core name in the European auto sector, with investors closely...

This article examines whether Deutsche Post shares still offer value at current levels or whether the recent strength has already priced in the upside, using the available numbers to assess the stock. Over the last week the share price return is 5.4%, with 9.2% over the past month, 7.4% year to date and 38.7% over the past year. These figures can influence how investors think about both opportunity and risk. Recent coverage has focused on Deutsche Post as a global logistics and parcel...

Investors may be wondering whether Deutsche Telekom's share price reflects its true worth, or if the market is mispricing this telecom heavyweight right now. The stock last closed at €27.57, with a 10.4% decline over 30 days and a 10.3% decline over 1 year, despite longer term returns of 41.7% over 3 years and 96.4% over 5 years, which hint at a very different picture. Recent headlines have focused on Deutsche Telekom's position within the European telecom sector, including its role in...

It looks like Daimler Truck Holding AG ( ETR:DTG ) is about to go ex-dividend in the next 4 days. The ex-dividend date...

adidas AG ( ETR:ADS ) just released its latest first-quarter results and things are looking bullish. Results were good...

If you are wondering whether Deutsche Lufthansa’s €7.33 share price offers value or risk at today’s levels, key clues sit in how the market is currently weighing its fundamentals. The stock has returned 1.1% over the last 7 days, while the 30 day performance is a 2.3% decline and the year to date move is a 14.6% decline, set against an 18.9% gain over the past year and a 12.6% decline over 3 years. Investors have been reacting to ongoing sector wide themes such as capacity planning, cost...

Merck KGaA (XTRA:MRK) announced a collaboration with Remepy to develop Hybrid Drugs that pair pharmaceuticals with app-based digital therapeutics for rare and difficult-to-treat cancers. The company also introduced its first bio-based solvent portfolio for high-performance liquid chromatography, aimed at supporting more sustainable laboratory operations. For you as an investor, these moves highlight how Merck KGaA is leaning into two active themes in healthcare: digital therapeutics and...

Heidelberg Materials: recent share performance in focus Heidelberg Materials (XTRA:HEI) has drawn attention after recent share performance, with a roughly 5.6% move over the past month contrasting with an 18.6% decline over the past 3 months. For investors tracking entry points and sentiment shifts, those short term and quarterly returns sit alongside a year to date loss of about 15.1% and a 1 year total return close to 10%. See our latest analysis for Heidelberg Materials. At a share price...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see BASF SE...

PUMA (XTRA:PUM) has just posted its Q1 2026 scorecard, and investors are coming off a volatile 2025 where quarterly revenue moved from €2.08b in Q1 to €1.56b in Q4 while EPS swung from a small profit of essentially €0.00 in Q1 to a loss of €2.28 per share in Q4. Over the same stretch, net income shifted from a €0.5m profit in Q1 2025 to a €336.3m loss by Q4 as revenue stepped down from €2.31b in Q3 2024 to €1.56b in Q4 2025, which puts the spotlight firmly on how much of each euro of sales is...

If you are wondering whether Allianz is fairly priced or has more room to run, an effective starting point is to look closely at what the current share price implies about its value. The stock recently closed at €389.00, with returns of 8.3% over 30 days, 11.4% over 1 year and 123.1% over 5 years. These figures can influence how much risk and upside investors feel is still on the table. Recent coverage around Allianz has focused on its position as a large European insurer, its capital...